Patents by Inventor Alexander Lynge Reese-Petersen

Alexander Lynge Reese-Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for Assessing Cancer
    Publication number: 20230358752
    Abstract: Described herein are immunoassay methods for detecting and/or monitoring a cancer in a patient by contacting a biofluid sample from a patient with a monoclonal antibody that specifically binds to a C-terminal epitope of type XXVIII collagen, and detecting and determining the amount of binding between the monoclonal antibody and peptides in the sample.
    Type: Application
    Filed: September 10, 2021
    Publication date: November 9, 2023
    Applicant: Nordic Bioscience A/S
    Inventors: Federica Genovese, Nicholas Willumsen, Alexander Lynge Reese-Petersen, Shu Sun, Morten Asser Karsdal
  • Assay for Assessing Heart Failure
    Publication number: 20230258658
    Abstract: Disclosed herein are immunoassays, in particular immunoassays for detecting and/or monitoring cardiovascular disease, such as heart failure. Also disclosed are monoclonal antibodies and kits for use in said assays. The assays, antibodies and kits target a C-terminal epitope of type XXVIII collagen.
    Type: Application
    Filed: September 3, 2020
    Publication date: August 17, 2023
    Applicant: Nordic Bioscience A/S
    Inventors: Shu Sun, Alexander Lynge Reese-Petersen, Federica Genovese, Morten Karsdal